Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > VIR Vir Biotechnology > Detailed Quotes

VIR Vir Biotechnology

Watchlist
27.070
-2.380-8.08%
Close  02/08 16:00 ET
27.0700.0000.00%
Post Mkt Price 02/08 16:08 ET
High
29.050
Open
29.050
Turnover
26.08M
Low
27.040
Pre Close
29.450
Volume
940.96K
Market Cap
3.60B
P/E(TTM)
3.18
52wk High
33.110
Shares
133.12M
P/E(Static)
6.84
52wk Low
18.050
Float Cap
2.16B
Bid/Ask %
0.00%
Historical High
141.010
Shs Float
79.97M
Volume Ratio
1.30
Historical Low
11.650
Dividend TTM
--
Div Yield TTM
--
P/B
1.68
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
1.18%
Amplitude
6.83%
Avg Price
27.717
Lot Size
1
Float Cap
2.16B
Bid/Ask %
0.00%
Historical High
141.010
Shs Float
79.97M
Volume Ratio
1.30
Historical Low
11.650
Dividend TTM
--
P/B
1.68
Dividend LFY
--
Turnover Ratio
1.18%
Amplitude
6.83%
Avg Price
27.717
Lot Size
1
Price Forecast

News

Comment

Company Overview More
Vir Biotechnology, Inc. operates as a clinical-stage immunology company that focuses on combining immunologic insights with cutting-edge technologies to treat and prevent serious infectious diseases. The firm's technology platforms include antibody, T cell, innate immunity and siRNA, which are designed to stimulate and enhance the immune system by exploiting critical observations of natural immune processes. The company was founded by Robert Taylor Nelsen, Klaus Frueh, Jay Parrish, Lawrence Corey, and Louis Picker in April 7, 2016 and is headquartered in San Francisco, CA.
CEO: Dr. George A. Scangos,PhD
Market: NASDAQ
Listing Date: 10/11/2019
Paper Trade More
Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist